7T MRI Scan for Brain Cancer

Overseen By Max Wintermark

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: M.D. Anderson Cancer Center

Disqualifiers: Pregnancy, Renal failure, Claustrophobia, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

50 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial investigates how well 7T MRI scan works in imaging central nervous system tumors. Diagnostic procedures, such as 7T MRI, may help find and diagnose central nervous system tumors and help measure a patient's response to earlier treatment. The goal of this trial is to learn if a new MRI system can provide better quality images than a standard MRI.

Who Is on the Research Team?

Max Wintermark

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

This trial is for adults with new or suspected recurrent central nervous system tumors, including gliomas and metastases. Participants may have had previous treatments like surgery or chemotherapy. They must have a tumor of at least 5mm that's visible on an MRI scan and not be pregnant, claustrophobic, allergic to contrast agents used in MRIs, or have renal failure.

Inclusion Criteria

I have a newly diagnosed brain tumor or cancer spread to the brain that is at least 5 mm.

My doctors suspect my cancer has returned and agree it looks like it's recurring.

Experts agree I likely have a brain tumor or cancer spread to the brain.

Exclusion Criteria

You are unable to have a magnetic resonance imaging (MRI) scan for medical reasons.

You have certain types of implants or medical devices that can't be used with MRI machines, or you have conditions like pregnancy, kidney problems, or claustrophobia that can make getting an MRI unsafe for you.

You have metal objects inside your body that could be unsafe during an MRI scan.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Diagnostic Imaging

Participants undergo 7T MRI to assess imaging quality and contrast-to-noise ratio

1 day

1 visit (in-person)

Follow-up

Participants are monitored for imaging outcomes and patient satisfaction

1 year

What Are the Treatments Tested in This Trial?

Interventions

• 7 Tesla Magnetic Resonance Imaging

Trial Overview The study is testing the effectiveness of a high-resolution 7T MRI scan compared to standard MRI scans in detecting and monitoring brain tumors. It aims to determine if the newer technology provides clearer images for better diagnosis and treatment evaluation.

How Is the Trial Designed?

Group I: Diagnostic (7T MRI) Experimental Treatment 2 Interventions

Patients undergo 7T MRI over 60 minutes.

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials

3,107

Recruited

1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+